Intellia Therapeutics Head office building

Investors
& Media

Banner Menu

Press Releases

Intellia Therapeutics to Participate in Upcoming Investor Conferences

Read More

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More

Stock Information

Minimum 15 minutes delayed. Source: LSEG